Summary
The WHO's International Agency for Research on Cancer has classified three common medicines—hydrochlorothiazide, voriconazole, and tacrolimus—as carcinogenic, placing them in Group 1 of the IARC Monographs. Doctors advise patients not to discontinue prescribed treatments for high blood pressure, fungal infections, and organ transplant rejection.